Effects of testosterone therapy in women – new systematic review and meta-analysis

Categories: , , , , ,

It has been over a decade since the last systematic review and meta-analysis on the effects of testosterone for women was conducted as an update to the the 2005 Cochrane Review .

In January 2019 the medical journal Systematic Reviews published the proctcol for a review that will identify and evaluate studies that have examined the effects of testosterone therapy for women on a range of outcomes including sexual fucntion, cardiovascular events, metabolic paramaters, musculosketetal health, wellbeing, cancer events, androgenic effects and withdrawal rates.

Researchers from the Women’s Health Research Program and the School of Publoic Health and Preventive Medicine at Monash University in Melbourne will undertake the comprehensive systematic review with meta-analysis.

The authors state “This review will provide a critical basis for the development of evidence-based clinical guidelines for the indications and contra-indications to therapy, the benefits and risks of therapy, the areas of clinical uncertainty and the assessment and monitoring of patients.” 

Reference: Systematic Reviews (2019) 8:19 Free PMC

Latest News


Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido

International Society For Sexual Medicine Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido    

NEW IMS Symposium with Dr James Simon & Sharon Parish NEW IMS Symposium with Dr James Simon & Sharon Parish

Sexual Health and Treatment for Women: Fact, Fiction, the Future. At the International Menopause Society’s 19th World Congress on Menopause to be held 19th – 22nd October 2024 in… Continue Reading →

INTERNATIONAL RECOGNITION PROCEDURE OFFERS HOPE FOR UK’S POSTMENOPAUSAL WOMEN. INTERNATIONAL RECOGNITION PROCEDURE OFFERS HOPE FOR UK’S POSTMENOPAUSAL WOMEN.

Hypoactive Sexual Desire Dysfunction (HSDD) Perth, Australia: Lawley Pharmaceuticals, via UK-based commercial partner, Andro Pharmaceuticals Ltd, today submitted a Marketing Authorisation Application (MAA) for… Continue Reading →